Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

FOLFOX6 chemotherapy effectively reduces VEGF levels and improves quality of life in advanced colorectal cancer patients.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

YH0618 granules may help prevent hair loss in breast cancer patients undergoing chemotherapy.

Topical vitamin D3 does not prevent hair loss from chemotherapy.

A woman's hair turned gray and fell out after starting a cancer drug called imatinib mesylate.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Trilostane helped a dog with an adrenal tumor feel better and stay healthy.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

Treatment strategies for breast cancer affect blood health, causing issues like anemia and require nutritional counseling.

Targeting ornithine decarboxylase can help prevent skin cancer.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.

A topical BRAF inhibitor, vemurafenib, can speed up wound healing and promote hair growth, especially in diabetic patients.

Dutasteride successfully treated a woman's hair loss when other treatments failed.

The (+) enantiomer of YH239-EE effectively kills breast cancer cells.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

The FDA approved a new Pfizer drug for hair loss in teens.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

Dutasteride effectively treats benign prostatic hyperplasia but isn't approved for preventing prostate cancer.

A new therapy for a skin blistering condition has not been developed yet.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

Adalimumab significantly improves quality of life for patients with moderate to severe hidradenitis suppurativa.

Etrasimod is safe but not effective for severe alopecia areata, though it may help milder cases.

A woman regrew her hair after receiving injections of special cell-derived vesicles.

TCDD changes skin cell growth and keratin production in mice.